Value-based care models — particularly Medicare's Comprehensive Care for Joint Replacement bundled payment program and its successor models — are fundamentally changing how orthopedic implants and services are purchased and reimbursed. Under bundled payments, hospitals and surgeons share financial risk for the total cost of a joint replacement episode, creating powerful incentives to select implants and technologies that reduce complications, readmissions, and extended care utilization.
Topics Covered
• CJR and Bundled Payment Models
• Outcomes Measurement Frameworks
• Implant Cost in Bundled Episodes
• OEM Value-Based Contracting
• Real-World Evidence and Outcomes Data
• Post-Acute Care Optimization
Table of Contents
1. Executive Summary
2. Market Overview
3. CJR and Bundled Payment Models
4. Outcomes Measurement Frameworks
5. Implant Cost in Bundled Episodes
6. OEM Value-Based Contracting
7. Real-World Evidence and Outcomes Data
8. Post-Acute Care Optimization
9. Regional Market Analysis
10. Strategic Conclusions and Recommendations
11. Appendix
List of Tables
Table 1. Market Overview and Key Data 2025
Table 2. Competitive Landscape 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Suppliers — Portfolio and Strategy Assessment 2025
Table 4. M&A and Partnership Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Amedisys
DePuy Synthes
Kindred
LifePoint
Stryker
UnitedHealth Group
Zimmer Biomet
